CCReW Clinical Trial/Research News 2 Aug 22

Dear

It's been great to see our Facebook group slowly growing with members starting to share more posts. To give you a taster, Jack shared his STARDIT initiative paper, Deb shared a paper led by consumers discussing community input in a genomic health implementation program, Hilary and Curtin Involve shared research posts, Joanne shared information on the 1st World Patients Conference, plus lots more. Though it is a private group, anyone with an interest in research, willing to act respectfully in the group, is welcome to request access. So don't be shy if that's you.

I've put out a call this week to our Facebook group for people interested in helping pull together some guidance for conference organisers looking for pointers on how to be more inclusive of patients and carers, as part of our #ptinclusiveconf advocacy. If you are interested in helping, let us know. Equally, if you have been involved in organisating a conference that was patient inclusive, let us know your tips for success, so others can learn from you.

As always, wishing you happiness and abundant kindness until the next newsletter hits your inbox.

Janelle.

AccessCR and the CCReW initiative

This is a list of all studies on the ANZCTR approved by a human research ethics committee, recruiting in Australia, with a trial start date between 18 July - 1 August 2022, as at 1Aug22.

A randomised evaluationtrial of the Life Flex digital health program for anxiety and depressive symptoms. This randomised controlled treatment study is looking for 150 people from across Australia aged 18 years or older concerned about their anxiety and/or depressive symptoms with internet access.
An open trial evaluation of the benzodiazepine (information and reduction) digital health program (BDZ digital health) for people using benzodiazepines. This open study is looking for 52 people from across Australia aged 18years or older, currently using benzodiazepines with access to the internet
A Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single, Ascending, Subcutaneous Doses of FT-104 HCl In Healthy Volunteers Safety, Tolerability, and Pharmacokinetics of Subcutaneous FT-104 HCl (SAIL-101). This Phase 1 placebo controlled safety and tolerability study running in Adelaide is looking for 32 healthy people aged 18-65 years.
Investigating the safety and efficacy of NEO-adjuvant chemo-IMmunotherapy in PAnCreaTic cancer, NEO-IMPACT. This open label non-randomised Phase 2 study running at centres in NSW and VIC is looking for 20 people aged 18 or older with specific types of pancreatic cancer.
A Phase II, prospective, open-label, dual-centre, single-arm feasibility study of Pregabalin for the management of uraemic pruritus in patients with End Stage Kidney Disease (ESKD) who are conservatively managed.. This Phase 2, non-randomised treatment study running at 2 centres in Sydney NSW is looking for 24 people aged 18years of older with moderate to severe uraemic pruritus and chronic itch
A single-site study of the effectiveness of Dapagliflozin for diabetic patients admitted to the intensive care unit. This Phase 2 placebo-controlled drug trial running in Melbourne Vic is looking for 40 people aged 18 years or older with a diagnosis of Type 2 diabetes that are expected to be admitted to the intensive care unit for a couple of days.
The activity and tolerability of Aromatase inhibitor plus PI3KCA inhibitor or CDK4/6 inhibitor in women with hormone receptor positive recurrent/metastatic gynaecological neoplasms (PARAGON-II) . This open-label, non-randomised Phase 2 study running in NSW and VIC is looking for 182 post-menopausal women aged 18years or older with one of a range of gynaecological cancers.

To learn more about any of these studies, please contact the research teams directly via the links. And if you are not living near a research centre but interested in a study they are running, it may still be worth speaking to the research team to discuss options. If you have problems contacting the researchers, please let us know.

AccessCR has no relationship with any of these projects and conducts this search of the public register to help people know as soon as possible about the research looking for participants.

If you'd like to proactively advertise a research study, then get in touch. The first listing of a newly recruiting study is free, and subsequent listings are available at a small cost. Advertising your trial will help the CCReW know about it, and will help us sustain this free CCReW support service.

We love to hear your stories as trial participants, consumers involved in research or the carers and family that help support people do either. It helps us promote your good works, uncover areas for improvement, and inspire others as to what is possible.

Our concept research participation experience survey is online for anyone that would like to record/note their trial-related experiences over time, as often as you'd like to, from looking for trials, to finishing up a trial. Once completed, you will be emailed your responses to do with as you like. You may choose to send them on to the research centre you are visiting, or not.

Alternatively, we are happy to receive stories by email, talk to you on the phone or a video call, or any other way you'd like to share your story with us.

The following are some activities that have come across our desk that people may be interested in:

The Cancer Council NSW has put out a call for consumers to submit an Expression of Interest (EOI) by Monday 29 August 2022 if interested in attending their next, free, 'Consumers in Research' training online workshop on 21 Sep 2022, 10-12.30pm. Click for more information on the training, to submit an EOI, or read more about working with researchers. Alternatively, please email Cancer Council NSW for more information at: research@nswcc.org.au.
The South Australian Health and Medical Research Institute (SAHMRI) will be opening our doors to the public on Sunday, 14 August.
National Science Week is on the 13-21 August. Find an event near you to explore here.

If you'd like to proactively advertise a research opportunity or event, then please get in touch for more information.